Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02034461 · ClinicalTrials.gov registry record · NA

Micro-Electrodes Implanted in a Human Nerve

A NA study, sponsored by University of Utah.

Terminated
Registry status
NA
Development phase
11
Enrollment target

NCT02034461: Clinical Trial NA study, sponsored by University of Utah.

NCT02034461 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02034461, a NA study, was terminated before completion, sponsored by University of Utah.

TERMINATED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

The main objective of the intervention in the study is devise feasibility using high-count microelectrode arrays implanted into peripheral nerves of patients with limb amputations or peripheral nerve injury. These microelectrodes will be custom-made and are not available for commercial distribution. The investigators hypothesize that recording neural signals from a large number of microelectrodes will provide selective motor information in high enough numbers to allow control over future artificial devices with many moving parts, i.e. artificial limbs with shoulder, elbow, wrist, and/or individual fingers that move. These studies will also investigate to what extent microstimulation of nerve fibers can provide sensory feedback from a prosthetic limb. The investigators will also conduct up to three acute surgeries where a Utah slanted Electrode Array (USEA) will be implanted in volunteers who are about to undergo limb amputations. These acute implantations will provide Dr. Hutchinson with human surgical experience in implanting USEAs and evaluating the containment system we will be using to immobilize the implanted USEA in the nerve.

Primary Outcome

Device feasibility evaluation to confirm design and operating specifications of the device to collect action potentials from peripheral nerves.

Interventions

  • DEVICE Utah Slanted Electrode Array

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2013-04
Est. Completion 2021-04
Phase NA
University of Utah

818 total trials

Why NCT02034461 stopped before completion

NCT02034461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Utah Slanted Electrode Array is the first listed.

NCT02034461 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02034461 about?

NCT02034461 is a clinical study titled "Micro-Electrodes Implanted in a Human Nerve". The main objective of the intervention in the study is devise feasibility using high-count microelectrode arrays implanted into peripheral nerves of patients with limb amputations or peripheral nerve injury. These microelectrodes will be custom-made and are not available for commercial distribution....

What is the current status of trial NCT02034461?

This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2013-04. Estimated completion is 2021-04.

What interventions are being tested in trial NCT02034461?

The interventions under investigation include: Utah Slanted Electrode Array (DEVICE).

Who is sponsoring clinical trial NCT02034461?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02034461's enrollment target sits among peer trials

11 1927th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02034461, the US trial registry maintained by the National Library of Medicine. NCT02034461 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.